| Year |
Citation |
Score |
| 2019 |
Granata V, Fusco R, Maio F, Avallone A, Nasti G, Palaia R, Albino V, Grassi R, Izzo F, Petrillo A. Qualitative assessment of EOB-GD-DTPA and Gd-BT-DO3A MR contrast studies in HCC patients and colorectal liver metastases. Infectious Agents and Cancer. 14: 40. PMID 31798677 DOI: 10.1186/s13027-019-0264-3 |
0.3 |
|
| 2016 |
Bimonte S, Leongito M, Piccirillo M, de Angelis C, Pivonello C, Granata V, Izzo F. Radio-frequency ablation-based studies on VX2rabbit models for HCC treatment. Infectious Agents and Cancer. 11: 38. PMID 27525037 DOI: 10.1186/s13027-016-0082-9 |
0.304 |
|
| 2015 |
Bimonte S, Barbieri A, Palaia R, Leongito M, Albino V, Piccirillo M, Arra C, Izzo F. An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma. Infectious Agents and Cancer. 10: 9. PMID 25755676 DOI: 10.1186/s13027-015-0004-2 |
0.305 |
|
| 2013 |
Costantini S, Capone F, Maio P, Guerriero E, Colonna G, Izzo F, Castello G. Cancer biomarker profiling in patients with chronic hepatitis C virus, liver cirrhosis and hepatocellular carcinoma. Oncology Reports. 29: 2163-8. PMID 23564159 DOI: 10.3892/or.2013.2378 |
0.312 |
|
| 2002 |
Curley SA, Izzo F. Radiofrequency ablation of primary and metastatic liver tumors. Surgical Technology International. 10: 99-106. PMID 12384870 |
0.308 |
|
| 2000 |
Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Annals of Surgery. 232: 381-91. PMID 10973388 DOI: 10.1097/00000658-200009000-00010 |
0.305 |
|
| Show low-probability matches. |